Isolation and Characterization of Lytic Proteus Virus 309

Joshua Aaron1, Leonardo J van Zyl2, Leon M T Dicks1

  • 1Department of Microbiology, Stellenbosch University, Stellenbosch 7600, South Africa.

Viruses
|June 24, 2022
PubMed

Insights

A novel bacteriophage, Proteus_virus_309, effectively lyses Proteus mirabilis, a common cause of complicated urinary tract infections. This discovery offers a promising alternative to antibiotics for treating challenging bacterial infections.

Area of Science:

  • Microbiology
  • Virology
  • Infectious Diseases

Background:

  • Proteus mirabilis frequently causes complicated urinary tract infections (UTIs), including catheter-associated UTIs (CAUTIs).
  • P. mirabilis biofilm formation complicates treatment, potentially leading to severe conditions like pyelonephritis, kidney failure, and urosepsis.
  • Antibiotic resistance is a growing concern in treating persistent P. mirabilis infections.

Purpose of the Study:

  • To isolate and characterize a bacteriophage with lytic activity against P. mirabilis.
  • To evaluate the potential of bacteriophage therapy as an alternative treatment for P. mirabilis infections.

Main Methods:

  • Isolation of bacteriophage 309 from a wastewater treatment facility.
  • Genomic characterization of bacteriophage 309 (41,740 bp).
  • Determination of lytic activity and host range against P. mirabilis strains.

Main Results:

  • A highly lytic bacteriophage, designated Proteus_virus_309, was isolated.
  • Proteus_virus_309 belongs to the genus Novosibovirus, according to ICTV guidelines.
  • The bacteriophage demonstrated strain-specific lysis of P. mirabilis within 20 minutes.

Conclusions:

  • Proteus_virus_309 is a potent lytic bacteriophage effective against P. mirabilis.
  • Bacteriophage therapy presents a promising alternative for managing difficult P. mirabilis UTIs, potentially overcoming antibiotic resistance.

Related Concept Videos